[go: up one dir, main page]

AR065318A1 - Formulaciones liquidas de formacion de pelicula dermal para liberacion de droga a la piel - Google Patents

Formulaciones liquidas de formacion de pelicula dermal para liberacion de droga a la piel

Info

Publication number
AR065318A1
AR065318A1 ARP080100604A ARP080100604A AR065318A1 AR 065318 A1 AR065318 A1 AR 065318A1 AR P080100604 A ARP080100604 A AR P080100604A AR P080100604 A ARP080100604 A AR P080100604A AR 065318 A1 AR065318 A1 AR 065318A1
Authority
AR
Argentina
Prior art keywords
skin
film formation
drug release
liquid formulations
chitosan
Prior art date
Application number
ARP080100604A
Other languages
English (en)
Inventor
Federico Mailland
Michela Legora
Original Assignee
Polichem Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38171596&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR065318(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Polichem Sa filed Critical Polichem Sa
Publication of AR065318A1 publication Critical patent/AR065318A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/02—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings containing insect repellants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dispersion Chemistry (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La presente está dirigida a composiciones líquidas que contienen quitosano, un derivado de quitosano o una sal fisiologicamente aceptable del mismo, formando una película termal luego de la aplicacion en la piel, util para el envío de activos libres sobre la superficie de la piel y en la stratum corneum. Reivindicacion 1: Una composicion líquida que comprende: a) un quitosano, un derivado de quitosano o una sal fisiologicamente aceptable del mismo, b) al menos un ingrediente activo cosmético o farmacéutico, y c) al menos un solvente volátil, en donde dicha composicion envía principios activos a la superficie de la piel.
ARP080100604A 2007-02-15 2008-02-12 Formulaciones liquidas de formacion de pelicula dermal para liberacion de droga a la piel AR065318A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90140507P 2007-02-15 2007-02-15
EP07102449A EP1958613A1 (en) 2007-02-15 2007-02-15 Dermal film-forming liquid formulations for drug release to skin

Publications (1)

Publication Number Publication Date
AR065318A1 true AR065318A1 (es) 2009-05-27

Family

ID=38171596

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080100604A AR065318A1 (es) 2007-02-15 2008-02-12 Formulaciones liquidas de formacion de pelicula dermal para liberacion de droga a la piel

Country Status (22)

Country Link
US (1) US20100062083A1 (es)
EP (2) EP1958613A1 (es)
JP (1) JP5376372B2 (es)
KR (1) KR20090119878A (es)
CN (2) CN103751790A (es)
AR (1) AR065318A1 (es)
BR (1) BRPI0721305A2 (es)
CA (1) CA2675568C (es)
CL (1) CL2008000442A1 (es)
CO (1) CO6210803A2 (es)
EA (1) EA019102B1 (es)
EC (1) ECSP099635A (es)
IL (2) IL199841A (es)
MA (1) MA31238B1 (es)
ME (1) ME00829B (es)
MX (1) MX2009008515A (es)
MY (1) MY161895A (es)
NO (1) NO20092998L (es)
NZ (1) NZ578611A (es)
UA (1) UA97134C2 (es)
WO (1) WO2008098634A1 (es)
ZA (1) ZA200904945B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS20050557A (sr) 2003-01-24 2007-09-21 Connetics Australia Pty Ltd., Klindamicin fosfat u obliku pene
EP2153836A1 (en) * 2008-08-04 2010-02-17 Polichem S.A. Film-forming liquid formulations for drug release to hair and scalp
EP2116237A1 (en) * 2008-08-05 2009-11-11 Polichem SA Compositions for treating rosacea comprising chitosan and a dicarboxylic acid
CA2753497C (en) 2009-02-25 2016-07-05 Stiefel Research Australia Pty Ltd Topical foam composition
WO2010127231A2 (en) 2009-05-01 2010-11-04 Signal Investment And Management Co. Moisturizing antimicrobial composition
WO2011024168A2 (en) * 2009-08-26 2011-03-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd Sustained release delivery systems for the prevention and treatment of head and neck cancers
JP5833007B2 (ja) * 2009-08-31 2015-12-16 ドクター・レディーズ・ラボラトリーズ・リミテッド ステロイドを含む局所製剤
EP3403654B1 (en) 2009-10-01 2019-07-31 Adare Development I, L.P. Orally administered corticosteroid compositions
GB2477768A (en) * 2010-02-12 2011-08-17 Chao-Ho Liu Pharmaceutical material for treating psoriasis
CA2816872C (en) * 2010-11-04 2019-02-12 442 Ventures, Llc Composition and method for treating skin conditions
CN102210746B (zh) * 2011-04-08 2012-11-07 福建美菰林生物科技有限公司 治疗足部真菌感染的乳膏药物组合物及其制备方法
EP2808030A4 (en) * 2011-11-22 2015-06-03 Univ Dongguk Ind Acad Coop COMPOSITION FOR THE PREVENTION, TREATMENT OR TREATMENT OF ATOPIC DERMATITIS WITH IMMUNOSUPPRESSIVE AND TRANSGLUTAMINEASE 2 INHIBITOR
US10232047B2 (en) * 2011-12-20 2019-03-19 Vyome Biosciences Private Limited Topical oil composition for the treatment of fungal infections
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
AU2014373683B2 (en) 2013-12-31 2020-05-07 Rapamycin Holdings, Llc Oral rapamycin nanoparticle preparations and use
CN106551931A (zh) * 2016-04-11 2017-04-05 张梦兮 1-羟基-2-吡啶酮类化合物在制备口腔黏膜疾病治疗药物上的用途
JP6660258B2 (ja) * 2016-06-20 2020-03-11 ライオン株式会社 制汗剤組成物
TWI777515B (zh) 2016-08-18 2022-09-11 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法
JP2022127602A (ja) * 2021-02-19 2022-08-31 アース製薬株式会社 噴霧された粒子の収縮を抑制する方法
CN120478204A (zh) * 2025-06-20 2025-08-15 诺德溯源(广州)生物科技有限公司 一种智能缓解须后刺激的舒缓修护组合物及应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1170188A (en) * 1967-09-15 1969-11-12 Bayer Ag N-trityl-imidazoles and salts and uses thereof
US4117118A (en) * 1976-04-09 1978-09-26 Sandoz Ltd. Organic compounds
IL73534A (en) * 1983-11-18 1990-12-23 Riker Laboratories Inc 1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
DE3421363A1 (de) * 1984-06-08 1985-12-12 Bayer Ag, 5090 Leverkusen Verfahren und vorrichtung zum kontinuierlichen herstellen von gegenstaenden oder beschichtungen mit kompliziert geformten konturen
US4822604A (en) * 1985-05-20 1989-04-18 S. C. Johnson & Son, Inc. Local treatment of dandruff, seborrheic dermatitis, and psoriasis
DE3541305A1 (de) * 1985-11-22 1987-05-27 Wella Ag Kosmetische mittel auf der basis von n-hydroxypropylchitosanen, neue n-hydroxypropyl-chitosane sowie verfahren zu ihrer herstellung
US4946870A (en) * 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
US5300494A (en) * 1986-06-06 1994-04-05 Union Carbide Chemicals & Plastics Technology Corporation Delivery systems for quaternary and related compounds
US5395305A (en) * 1990-08-30 1995-03-07 Terumo Kabushiki Kaisha Multilayer wound covering materials comprising a supporting layer and a moisture permeation controlling layer and method for their manufacture
JPH0543480A (ja) * 1991-08-08 1993-02-23 Nippon Soda Co Ltd 活性ペプタイド含有キトサン誘導体フイルム剤
JPH05339152A (ja) * 1992-06-09 1993-12-21 Nippon Soda Co Ltd 皮膚病変局所投与薬剤含有キトサン誘導体フィルム剤
GB9411530D0 (en) * 1994-06-09 1994-08-03 Quayle Rachel A Use of polymers as film-forming barrier materials
SE9402531L (sv) * 1994-07-19 1996-01-20 Medicarb Ab Sårläkningsmedel
SE9604610D0 (sv) * 1996-12-16 1996-12-16 Noviscens Ab Medical composition
US6231875B1 (en) * 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
DE10035991A1 (de) * 2000-07-24 2002-02-14 Polichem Sa Nagellackzusammensetzung
EP1179352A1 (en) * 2000-08-08 2002-02-13 MONTERESEARCH S.r.l. Topical composition for covering a skin lesion
NZ526806A (en) * 2001-01-09 2006-03-31 Israel Dvoretzky Therapeutic film forming composition and treatment system
US7297343B2 (en) * 2001-07-31 2007-11-20 Biosurface Engineering Technologies, Inc. Bioactive medical films
AU2002950506A0 (en) * 2002-07-31 2002-09-12 Soltec Research Pty Ltd Percutaneous delivery system
EP1491202A1 (en) * 2003-06-23 2004-12-29 Polichem S.A. Nail restructuring compositions for topical application
JP2005281654A (ja) * 2004-03-31 2005-10-13 Rikogaku Shinkokai 温度応答性組成物およびそのヒドロゲル

Also Published As

Publication number Publication date
WO2008098634A1 (en) 2008-08-21
MX2009008515A (es) 2009-08-20
JP5376372B2 (ja) 2013-12-25
IL199841A0 (en) 2010-04-15
ME00829B (me) 2012-03-20
BRPI0721305A2 (pt) 2014-03-25
US20100062083A1 (en) 2010-03-11
NZ578611A (en) 2012-08-31
KR20090119878A (ko) 2009-11-20
CO6210803A2 (es) 2010-10-20
AU2007346756A1 (en) 2008-08-21
MA31238B1 (fr) 2010-03-01
CN103751790A (zh) 2014-04-30
EA200901112A1 (ru) 2010-02-26
CA2675568A1 (en) 2008-08-21
EA019102B1 (ru) 2014-01-30
EP2117500A1 (en) 2009-11-18
EP1958613A1 (en) 2008-08-20
UA97134C2 (ru) 2012-01-10
IL241166A0 (en) 2015-11-30
CA2675568C (en) 2015-05-12
NO20092998L (no) 2009-09-14
CN101641082A (zh) 2010-02-03
AU2007346756A2 (en) 2009-09-24
CL2008000442A1 (es) 2008-08-22
ZA200904945B (en) 2010-09-29
JP2010518130A (ja) 2010-05-27
IL199841A (en) 2015-09-24
ECSP099635A (es) 2010-03-31
MY161895A (en) 2017-05-15

Similar Documents

Publication Publication Date Title
AR065318A1 (es) Formulaciones liquidas de formacion de pelicula dermal para liberacion de droga a la piel
CY1123334T1 (el) Σκευασματα φιναστεριδης για αποδεσμευση φαρμακου στα μαλλια και στο τριχωτο της κεφαλης
MX349176B (es) Suministro transdermico de farmaco empleando un osmolito y un agente vasoactivo.
MX2014015657A (es) Composicion topica que comprende un polimero formador de pelicula para liberar un ingrediente activo a la piel.
BR0318319A (pt) métodos de preparação e formulações/composições sustentadas pelo uso de dimeticona como veìculo
UY30373A1 (es) Derivados de fenilalanina, procedimientos de preparacion y aplicaciones
ES2361459A8 (es) Gel de quitosano para aplicaciones dermatológicas, proceso de obtención y uso del mismo.
ECSP088560A (es) Formulacion de liberacion sostenida que comprende octreotida y dos o mas polimeros de polilactido-co-glicolido
AR044872A1 (es) Composicion pulverizable que comprende un activo farmaceutico al menos una silicona volatil y una fase aceitosa no volatil
PE20110010A1 (es) Formulaciones liquidas de fenilefrina
TW200948402A (en) Composition for external use on skin
KR20100122511A (ko) 손 소독 패치
PE20090387A1 (es) Formulacion de pasireotida
AR061166A1 (es) Composiciones farmaceuticas para la liberacion sostenida de fenilferina
JP6193846B2 (ja) パック
AR107212A1 (es) Compuestos tópicos de matriz polimérica que comprenden una alta concentración de hialuronato de sodio biofermentado y sus usos
PA8615501A1 (es) Formulaciones farmaceuticas transdermicas
UY29989A1 (es) Composiciones farmacéuticas de agentes hipnoticos de accion corta en forma de liberación modificada y los procedimientos para preparar dichas formulaciones
BR9916814A (pt) Composição cosmética pulverizável e matriz utilizável nessa composição para uma administração dérmica
WO2016208044A1 (ja) パック
US20250281392A1 (en) Topical delivery of epinephrine and prodrug compositions
AR067561A1 (es) Medicamento para la aplicacion transdermica en animales
TH152684A (th) สูตรผสมของเหลวเพื่อการก่อรูปฟิล์มสำหรับการปลดปล่อยยาแก่ผมและหนังศีรษะ
TH101950B (th) สูตรผสมทางยาสำหรับให้ทางผิวหนัง
FR2954695B1 (fr) Utilisation dans des compositions cosmetiques et pharmaceutiques, d'un compose amplifiant la penetration et la retention cutanees de leurs ingredients actifs, et compositions cosmetiques et pharmaceutiques contenant ledit compose

Legal Events

Date Code Title Description
FB Suspension of granting procedure